Topper James N's Form 4 filing
Phathom Pharmaceuticals, Inc. (PHAT) · filed May 15, 2025
- Accession no.
- 0001415889-25-013134
- Filed
- May 15, 2025
- Trade date
- May 13-14, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $24.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Topper James NCIK 0001341382 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 13, 2025 | Common Stock | PPurchaseAcquired | +1,120 | $3.16 | +$3,539.2 | 49,323 | Indirect | |
| May 14, 2025 | Common Stock | PPurchaseAcquired | +6,300 | $3.32 | +$20,916 | 55,623 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.